Universal Health Realty Income Trust (UHT) Stock

UHT

Universal Health Realty Income Trust UHT · NYSE

$38.20 +0.87% (+$0.33)

Market cap: $526.3M
Enterprise value: $519.9M
P/E: 26.1x
Forward P/E: 21.9x
PEG: -
P/S: 4.3x
P/FCF: 10.9x
EV/EBITDA: 9.5x
ROIC: 32.9%
Gross margin: 72.3%
Net margin: 16.3%
Dividend yield: 7.90%
Payout ratio: 205.9%
Net debt/EBITDA: -0.1x
Beta: 0.85
Free float: 91.9%

Return vs S&P 500

Period	UHT	S&P 500	Difference
1 month	+1.3%	+0.9%	+0.4 pp
3 months	-13.4%	+3.8%	-17.2 pp
Year to date	-3.4%	+12.8%	-16.2 pp
1 year	+0.7%	+13.2%	-12.4 pp
3 years	-0.2%	+85.3%	-85.5 pp
5 years	-33.5%	+67.6%	-101.2 pp
10 years	-33.9%	+263.1%	-297.0 pp

Price change, dividends not included.

About the company

Universal Health Realty Income Trust operates as a real estate investment trust. It engages in investing and leasing healthcare and human service facilities through direct ownership or joint ventures. The firm focuses on investing in acute care hospitals, behavioral health care hospitals, free-standing emergency departments, childcare centers, and medical or office buildings. The company was founded on December 24, 1986 and is headquartered in King of Prussia, PA.

Sector

Real Estate

Industry

REIT - Healthcare Facilities

CEO

Alan Miller

Employees

Headquarters

King Of Prussia

Valuation

Is today's price reasonable?

What speaks for it: The share price is below the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

What to watch: Earnings per share fell by 6.0% a year over the last 3 years.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

What speaks for it: It earns 33 USD a year on every 100 USD of invested capital.

Financial health

Can it carry its debt?

What speaks for it: It has no debt and holds $6.47M in cash.
What to watch: Operating profit covers the interest on its debt only 1.3 times.

Capital and dividends

What does the company do with the money it earns?

What speaks for it: It has raised its dividend 38 years in a row.

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number